Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients von Nabi, Hafsah, Ibsen, Rikke, Ibsen, Michael, Kjellberg, Jakob, Hetland, Merete Lund, Glintborg, Bente

Volltext

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry von Nabi, Hafsah, Hendricks, Oliver, Jensen, Dorte Vendelbo, Loft, Anne Gitte, Pedersen, Jens Kristian, Just, Søren Andreas, Danebod, Kamilla, Munk, Heidi Lausten, Kristensen, Salome, Manilo, Natalia, Colic, Ada, Linauskas, Asta, Thygesen, Pia Høger, Christensen, Louise Brot, Kalisz, Maren Høgberget, Lomborg, Niels, Chrysidis, Stavros, Raun, Johnny Lillelund, Andersen, Marlene, Mehnert, Frank, Krogh, Niels Steen, Hetland, Merete Lund, Glintborg, Bente

Volltext

Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study von Tajchman, Daniel H, Nabi, Hafsah, Aslam, Mohsin, Butt, Jawad H, Grove, Erik L, Engstrøm, Thomas, Holmvang, Lene, Fosbøl, Emil L, Køber, Lars, Sørensen, Rikke

Volltext

Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data von Nabi, Hafsah, Rørth, Rasmus, Tajchman, Daniel H, Holmvang, Lene, Torp-Pedersen, Christian, Gislason, Gunnar, Fosbøl, Emil L, Køber, Lars, Sørensen, Rikke

Volltext